Abstract
β-Lactam resistance in Salmonella isolates is increasing. This paper describes the combination of three different β-lactamases, OXA-30, SHV-9 and CMY-7, expressed by an isolate of Salmonella enterica serotype Typhimurium. This is the first report of an isolate of Salmonella having both an extended-spectrum β-lactamase and an AmpC β-lactamase.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1011-1014 |
| Number of pages | 4 |
| Journal | Journal of Antimicrobial Chemotherapy |
| Volume | 49 |
| Issue number | 6 |
| State | Published - Jul 8 2002 |
All Science Journal Classification (ASJC) codes
- Pharmacology
- Microbiology (medical)
- Infectious Diseases
- Pharmacology (medical)
Fingerprint Dive into the research topics of 'Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 β-lactamases'. Together they form a unique fingerprint.
Cite this
Hanson, N. D., Moland, E. S., Hossain, A., Neville, S. A., Gosbell, I. B., & Thomson, K. S. (2002). Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 β-lactamases. Journal of Antimicrobial Chemotherapy, 49(6), 1011-1014.